Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.

@article{Selmi2016SerumAA,
  title={Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.},
  author={Carlo Selmi and Angela Ceribelli and Elena Generali and Carlo Alberto Scir{\`e} and Fausto Alborghetti and Guido Colloredo and Luisa Porrati and Maria I S Achenza and Maria de Santis and Francesca Cavaciocchi and Marco Sergio Massarotti and Natasa Isailovic and Valentina Paleari and Pietro Invernizzi and Torsten Matthias and Alberto Zucchi and Pier Luigi Meroni},
  journal={Autoimmunity reviews},
  year={2016},
  volume={15 2},
  pages={162-6}
}
The prevalence of ANA and anti-ENA in the general population is not well established, especially their clinical significance in healthy subjects. We herein determined the prevalence and predictive value of serum ANA and anti-ENA for connective tissue diseases (CTD), cancer, and mortality. We took advantage of a randomly selected sample of the 1998 general… CONTINUE READING